Congratulations to Dr Ross Chapman who has been awarded a 2019 Lister Prize! Image courtesy of Shutterstock These highly competitive prizes help support future leader in biomedicine and are awarded as a lump sum of £250,000 over five years, to fund developing a research programme which will aim to further our understanding of the fundamental DNA […]
Baroness Nicola Blackwood of North Oxford, Parliamentary Under Secretary of State for Innovation, has officially opened the Oxford BioEscalator. The BioEscalator is a new innovation centre for high-potential, early-stage medical science companies co-located alongside Oxford University’s world-class medical research at the Old Road Campus, Headington. It is one of four innovation centres in Oxfordshire supported […]
The report for the last year – 2018/2019 has been submitted to the DH via NIHR. In addition, a detailed summary of the last five years since designation was also submitted – this provides an excellent overview of the work of the AHSC and its partners. The documents are available here and (5 year report) […]
TheHill is delighted to announce that we will be hosting the Innovation Showcase at this year’s VentureFest at Oxford Brookes University. TheHill is Oxford’s digital health hub. We are an innovation cluster, network and support programme working in Oxford with NHS Trusts, universities, digital developers, innovators and investors to catalyse commercial and impactful technological solutions […]
New analysis shows the lower range of the licensed dose of the most commonly used second-generation antidepressants achieves the optimal balance between efficacy, tolerability and acceptability in the acute treatment of adults with major depression. A new study from Department of Psychiatry, Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a […]
A study including researchers in Nuffield Department of Population Health has found that government investment in healthcare research is good for the wider economy. The research, supported by the NIHR Oxford Biomedical Research Centre (BRC), found that the return on investment in the Oxford BRC was 46% in terms of income and job creation alone. […]
Peter Donnelly, Professor of Statistical Science in the Wellcome Centre Trust for Human Genetics (WCTHG) at Oxford and Chief Executive Officer of Genomics plc, a University spin-out, is knighted for services to the understanding of human genetics in disease.
Academic Industry Meeting Day – 4 July On Thursday 4 July, the NIHR Oxford BRC is organising an Academic Industry Meeting Day (AIMDay) at the Blavatnik School of Government as part of a series of networking events that enable industry groups and other external organisations to gain academic and clinical perspective into industry challenges. The event […]
Scientists in the Radcliffe Department of Medicine (RDM) have identified new genetic targets for disease research and potentially drug development. An international consortium of scientists, including RDM researchers, has analyzed protein-coding genes from nearly 46,000 people, linking rare DNA alterations to type 2 diabetes. The study, one of the largest known of its type, includes […]
The MSD Business Development & Partnering team have been shortlisted in the PraxisAuril and UK Research and Innovation (UKRI) 2019 Knowledge Exchange Awards, in the category of ‘Knowledge Exchange Team of the Year’ More information on the team and the Award can be found here